表紙
市場調查報告書

LDL (低密度脂蛋白) 檢驗的全球市場:產業趨勢與未來預測

Global LDL Test Market - Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 883707
出版日期 內容資訊 英文 350 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
LDL (低密度脂蛋白) 檢驗的全球市場:產業趨勢與未來預測 Global LDL Test Market - Industry Trends and Forecast to 2026
出版日期: 2019年06月01日內容資訊: 英文 350 Pages
簡介

本報告提供全球LDL膽固醇檢驗的市場相關分析,市場基本結構和促進、阻礙因素,整體市場規模趨勢預測,各零件、各疾病、各流通管道、各終端用戶、各地區的詳細趨勢,市場競爭環境,主要企業簡介等調查。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球LDL檢驗市場:各零件

  • 概要
  • 套件、試劑
  • 檢查裝置
    • 分光光度計
    • 注射器及注射針
    • 其他
  • 服務

第7章 全球LDL檢驗市場:各疾病

  • 概要
  • 糖尿病
  • 中風
  • 動脈粥狀硬化性心血管疾病
  • 肥胖症
  • 血脂異常症
  • 頸動脈疾病
  • 末稍血管疾病
  • 心絞痛
  • 其他

第8章 全球LDL檢驗市場:各流通管道

  • 概要
  • 直接購買
  • 零售

第9章 全球LDL檢驗市場:各終端用戶

  • 概要
  • 醫院
  • 診療所
  • 門診病人治療設施
  • 研究所

第10章 全球LDL檢驗市場:各地區

  • 概要
  • 北美 (美國,加拿大,墨西哥)
  • 歐洲 (德國,英國,法國,義大利,西班牙,瑞士,荷蘭,俄羅斯,比利時,土耳其等)
  • 亞太地區 (中國,日本,印度,澳洲,韓國,新加坡,馬來西亞,印尼,泰國,菲律賓等)
  • 南美 (巴西等)
  • 中東、非洲

第11章 企業環境

  • 各企業市場佔有率分析:全球整體
  • 各企業市場佔有率分析:北美市場
  • 各企業市場佔有率分析:歐洲市場
  • 各企業市場佔有率分析:亞太地區市場

第12章 SWOT分析

  • 市場調查分析

第13章 企業簡介

  • F. HOFFMANN-LA ROCHE LTD
    • 企業概要
    • 市場收益額分析
    • 企業佔有率分析
    • 各地區的存在感
    • 產品系列
    • 近幾年的主要趨勢
  • MERCK KGAA
  • ABBOTT
  • SEKISUI DIAGNOSTICS
  • ATLAS MEDICAL U.K
  • CELL BIOLABS, INC
  • DIASYS DIAGNOSTIC SYSTEMS GMBH
  • DIAZYME LABORATORIES, INC
  • EUROFINS SCIENTIFIC
  • EUROLYSER DIAGNOSTICA GMBH
  • EXPRESS BIOTECH INTERNATIONAL
  • HOME ACCESS HEALTH
  • LABORATORY CORPORATION OF AMERICA
  • QUEST DIAGNOSTICS
  • RANDOX LABORATORIES LTD
  • RECKONDIAGNOSTICS
  • THERMO FISHER SCIENTIFIC INC

第14章 結論

第15章 調查問卷

第16章 相關調查

目錄

Global LDL test market is expected to grow at a CAGR of 7.2% in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Major growing sectors under the market segmentation are as follows:

  • On the basis of components, kits & reagents segment is dominating the market as it shows the results within less period of time and it is easy to use. The kits & reagents are majorly preferred for diagnosis by the end users.
  • On the basis of disease, diabetes segment growing is dominating the market because increasing prevalence of diabetes also raise demand of LDL test to elevate risk of diabetes.
  • On the basis of distribution channel, a direct tender is expected to dominate the market due to increasing direct supply of LDL test devices kits and reagents into the hospitals and laboratories.
  • On the basis of end user, hospital is expected to dominating the market due to increasing use of LDL test devise and kits and reagents.

Key Market Players:

The key market players are listed below:

  • Quest Diagnostics
  • Sekisui Diagnostics
  • Express Biotech International
  • Randox Laboratories Ltd
  • Reckon diagnostics
  • Diasys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Eurolyser Diagnostica GmbH
  • Sigma-Aldrich
  • Diazyme Laboratories, Inc.
  • Laboratory Corporation of America
  • Cell Biolabs, Inc.
  • Atlas Medical U.K
  • Eurofins Scientific
  • Thermo Fisher Scientific Inc.
  • Home Access Health

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL LDL TEST MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GLOBAL LDL TEST MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 RESEARCH METHODOLOGY
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 DBMR MARKET CHALLENGE MATRIX
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 KEY PRIMARY INSIGHTS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 RISING AWARENESS AMONG PATIENT
    • 3.1.2 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND OBESITY
    • 3.1.3 INCREASING NUMBER OF GERIATRIC PEOPLE
    • 3.1.4 GOVERNMENT INITIATIVES TO IMPROVE QUALITY OF TESTING
  • 3.2 RESTRAINTS
    • 3.2.1 RISKS ASSOCIATED WITH TESTS LIKE BLEEDING AND INFECTION
    • 3.2.2 EMERGENCE OF NON-INVASIVE CHOLESTEROL TESTING METHODS
  • 3.3 OPPORTUNITIES
    • 3.3.1 HIGH GROWTH POSSIBILITY IN LDL TEST IN DEVELOPING COUNTRIES
    • 3.3.2 PATIENT-INITIATED TESTING
  • 3.4 CHALLENGES
    • 3.4.1 PATIENT DATA SECURITY
    • 3.4.2 EVOLVING REGULATORY POLICIES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL LDL TEST MARKET, BY COMPONENTS

  • 6.1 OVERVIEW
  • 6.2 KITS & REAGENTS
  • 6.3 DEVICES
    • 6.3.1 SPECTROPHOTOMETER
    • 6.3.2 SYRINGES AND NEEDLES
    • 6.3.3 OTHERS
  • 6.4 SERVICES

7 GLOBAL LDL TESTING MARKET, BY DISEASE

  • 7.1 OVERVIEW
  • 7.2 DIABETES
  • 7.3 STROKE
  • 7.4 ATHEROSCLEROSIS
  • 7.5 OBESITY
  • 7.6 DYSLIPIDEMIA
  • 7.7 CAROTID ARTERY DISEASE
  • 7.8 PERIPHERAL ARTERIAL DISEASE
  • 7.9 ANGINA
  • 7.10 OTHERS

8 GLOBAL LDL TEST MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 OVERVIEW
  • 8.2 DIRECT TENDERS
  • 8.3 RETAIL

9 GLOBAL LDL TEST MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 HOSPITALS
  • 9.3 CLINICS
  • 9.4 AMBULATORY CARE
  • 9.5 RESEARCH LABORATORY

10 GLOBAL LDL TEST MARKET, BY GEOGRAPHY

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S.
    • 10.2.2 CANADA
    • 10.2.3 MEXICO
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 U.K
    • 10.3.3 FRANCE
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 SWITZERLAND
    • 10.3.7 NETHERLANDS
    • 10.3.8 RUSSIA
    • 10.3.9 BELGIUM
    • 10.3.10 TURKEY
    • 10.3.11 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 JAPAN
    • 10.4.3 INDIA
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 SINGAPORE
    • 10.4.7 MALAYSIA
    • 10.4.8 INDONESIA
    • 10.4.9 THAILAND
    • 10.4.10 PHILIPPINES
    • 10.4.11 REST OF ASIA-PACIFIC
  • 10.5 SOUTH AMERICA
    • 10.5.1 BRAZIL
    • 10.5.2 REST OF SOUTH AMERICA
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 SOUTH AFRICA
    • 10.6.2 REST OF MIDDLE EAST AND AFRICA

11 GLOBAL LDL TEST MARKET, COMPANY LANDSCAPE

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE
  • 11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 SWOT ANALYSIS

  • 12.1 STRENGTH
  • 12.2 WEAKNESS
  • 12.3 OPPORTUNITY
  • 12.4 THREAT
  • 12.5 DATA BRIDGE MARKET RESEARCH ANALYSIS

13 COMPANY PROFILE

  • 13.1 F. HOFFMANN-LA ROCHE LTD
    • 13.1.1 COMPANY SNAPSHOT
    • 13.1.2 REVENUE ANALYSIS
    • 13.1.3 COMPANY SHARE ANALYSIS
    • 13.1.4 GEOGRAPHICAL PRESENCE
    • 13.1.5 PRODUCT PORTFOLIO
    • 13.1.6 RECENT DEVELOPMENTS
  • 13.2 MERCK KGAA
    • 13.2.1 COMPANY SNAPSHOT
    • 13.2.2 REVENUE ANALYSIS
    • 13.2.3 COMPANY SHARE ANALYSIS
    • 13.2.4 GEOGRAPHICAL PRESENCE
    • 13.2.5 PRODUCT PORTFOLIO
    • 13.2.6 RECENT DEVELOPMENT
  • 13.3 ABBOTT
    • 13.3.1 COMPANY SNAPSHOT
    • 13.3.2 REVENUE ANALYSIS
    • 13.3.3 COMPANY SHARE ANALYSIS
    • 13.3.4 GEOGRAPHICAL PRESENCE
    • 13.3.5 PRODUCT PORTFOLIO
    • 13.3.6 RECENT DEVELOPMENTS
  • 13.4 SEKISUI DIAGNOSTICS
    • 13.4.1 COMPANY SNAPSHOT
    • 13.4.2 COMPANY SHARE ANALYSIS
    • 13.4.3 GEOGRAPHICAL PRESENCE
    • 13.4.4 PRODUCT PORTFOLIO
    • 13.4.5 RECENT DEVELOPMENT
  • 13.5 ATLAS MEDICAL U.K
    • 13.5.1 COMPANY SNAPSHOT
    • 13.5.2 GEOGRAPHICAL PRESENCE
    • 13.5.3 PRODUCT PORTFOLIO
    • 13.5.4 RECENT DEVELOPMENTS
  • 13.6 CELL BIOLABS, INC
    • 13.6.1 COMPANY SNAPSHOT
    • 13.6.2 GEOGRAPHICAL PRESENCE
    • 13.6.3 PRODUCT PORTFOLIO
    • 13.6.4 RECENT DEVELOPMENTS
  • 13.7 DIASYS DIAGNOSTIC SYSTEMS GMBH
    • 13.7.1 COMPANY SNAPSHOT
    • 13.7.2 GEOGRAPHICAL PRESENCE
    • 13.7.3 PRODUCT PORTFOLIO
    • 13.7.4 RECENT DEVELOPMENT
  • 13.8 DIAZYME LABORATORIES, INC
    • 13.8.1 COMPANY SNAPSHOT
    • 13.8.2 GEOGRAPHICAL PRESENCE
    • 13.8.3 PRODUCT PORTFOLIO
    • 13.8.4 RECENT DEVELOPMENTS
  • 13.9 EUROFINS SCIENTIFIC
    • 13.9.1 COMPANY SNAPSHOT
    • 13.9.2 REVENUE ANALYSIS
    • 13.9.3 GEOGRAPHICAL PRESENCE
    • 13.9.4 PRODUCT PORTFOLIO
    • 13.9.5 RECENT DEVELOPMENT
  • 13.10 EUROLYSER DIAGNOSTICA GMBH
    • 13.10.1 COMPANY SNAPSHOT
    • 13.10.2 GEOGRAPHICAL PRESENCE
    • 13.10.3 PRODUCT PORTFOLIO
    • 13.10.1 RECENT DEVELOPMENTS
  • 13.11 EXPRESS BIOTECH INTERNATIONAL
    • 13.11.1 COMPANY SNAPSHOT
    • 13.11.2 GEOGRAPHICAL PRESENCE
    • 13.11.3 PRODUCT PORTFOLIO
    • 13.11.4 RECENT DEVELOPMENTS

  • 13.12 HOME ACCESS HEALTH
    • 13.12.1 COMPANY SNAPSHOT
    • 13.12.2 PRODUCT PORTFOLIO
    • 13.12.3 RECENT DEVELOPMENTS
  • 13.13 LABORATORY CORPORATION OF AMERICA
    • 13.13.1 COMPANY SNAPSHOT
    • 13.13.2 REVENUE ANALYSIS
    • 13.13.3 GEOGRAPHICAL PRESENCE
    • 13.13.4 PRODUCT PORTFOLIO
    • 13.13.5 RECENT DEVELOPMENTS
  • 13.14 QUEST DIAGNOSTICS
    • 13.14.1 COMPANY SNAPSHOT
    • 13.14.2 REVENUE ANALYSIS
    • 13.14.3 GEOGRAPHICAL PRESENCE
    • 13.14.4 PRODUCT PORTFOLIO
    • 13.14.5 RECENT DEVELOPMENT
  • 13.15 RANDOX LABORATORIES LTD
    • 13.15.1 COMPANY SNAPSHOT
    • 13.15.2 GEOGRAPHICAL PRESENCE
    • 13.15.3 PRODUCT PORTFOLIO
    • 13.15.4 RECENT DEVELOPMENT
  • 13.16 RECKONDIAGNOSTICS
    • 13.16.1 COMPANY SNAPSHOT
    • 13.16.2 PRODUCT PORTFOLIO
    • 13.16.3 RECENT DEVELOPMENTS
  • 13.17 THERMO FISHER SCIENTIFIC INC
    • 13.17.1 COMPANY SNAPSHOT
    • 13.17.2 REVENUE ANALYSIS
    • 13.17.3 GEOGRAPHICAL PRESENCE
    • 13.17.4 PRODUCT PORTFOLIO
    • 13.17.5 RECENT DEVELOPMENTS

14 CONCLUSION

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 GLOBAL LDL TEST MARKET, BY COMPONENTS, 2017- 2026 (USD MILLION)
  • TABLE 2 GLOBAL KITS & REAGENTS IN GLOBAL LDL TEST MARKET BY REGION, 2017-2026, USD MILLION
  • TABLE 3 GLOBAL DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026, USD MILLION
  • TABLE 4 GLOBAL DEVICES IN LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION
  • TABLE 5 GLOBAL SERVICES IN GLOBAL LDL TEST MARKET BY REGION, 2017-2026, USD MILLION
  • TABLE 6 GLOBAL LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 7 GLOBAL DIABETES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 GLOBAL STROKE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 GLOBAL ATHEROSCLEROSIS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 GLOBAL OBESITY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 11 GLOBAL DYSLIPIDEMIA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 GLOBAL CAROTID ARTERY DISEASE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13 GLOBAL PERIPHERAL ARTERIAL DISEASES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 14 GLOBAL ANGINA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 GLOBAL OTHERS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 GLOBAL LDL TEST MARKET, BY DRISTIBUTION CHANNEL, 2017- 2026 (USD MILLION)
  • TABLE 17 GLOBAL DIRECT TENTERS IN GLOBAL LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION
  • TABLE 18 GLOBAL RETAIL IN GLOBAL LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION
  • TABLE 19 GLOBAL LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 20 GLOBAL HOSPITALS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 GLOBAL CLINICS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22 GLOBAL AMBULATORY CARE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 GLOBAL RESEARCH LABORATORY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 24 GLOBAL LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 NORTH AMERICA LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 NORTH AMERICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 27 NORTH AMERICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 28 NORTH AMERICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 29 NORTH AMERICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 30 NORTH AMERICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 31 U.S. LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 32 U.S. DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 33 U.S. LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 34 U.S. LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 35 U.S LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 36 CANADA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 37 CANADA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 38 CANADA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 39 CANADA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 40 CANADA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 41 MEXICO LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 42 MEXICO DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 43 MEXICO LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 44 MEXICO LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 45 MEXICO LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 46 EUROPE LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 47 EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 48 EUROPE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 49 EUROPE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 50 EUROPE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 51 EUROPE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 52 GERMANY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 53 GERMANY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 54 GERMANY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 55 GERMANY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 56 GERMANY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 57 U.K LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 58 U.K DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 59 U.K LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 60 U.K LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 61 U.K LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 62 FRANCE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 63 FRANCE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 64 FRANCE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 65 FRANCE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 66 FRANCE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 67 ITALY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 68 ITALY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 69 ITALY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 70 ITALY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 71 ITALY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 72 SPAIN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 73 SPAIN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 74 SPAIN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 75 SPAIN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 76 SPAIN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 77 SWITZERLAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 78 SWITZERLAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 79 SWITZERLAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 80 SWITZERLAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 81 SWITZERLAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 82 NETHERLANDS LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 83 NETHERLANDS DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 84 NETHERLANDS LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 85 NETHERLANDS LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 86 NETHERLANDS LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 87 RUSSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 88 RUSSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 89 RUSSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 90 RUSSIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 91 RUSSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 92 BELGIUM LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 93 BELGIUM DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 94 BELGIUM LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 95 BELGIUM LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 96 BELGIUM LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 97 TURKEY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 98 TURKEY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 99 TURKEY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 100 TURKEY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 101 TURKEY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 102 REST OF EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 103 ASIA-PACIFIC LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 104 ASIA-PACIFIC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 105 ASIA-PACIFIC DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 106 ASIA-PACIFIC LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 107 ASIA-PACIFIC LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 108 ASIA-PACIFIC LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 109 CHINA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 110 CHINA DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026 (USD MILLION)
  • TABLE 111 CHINA DEVICES IN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 112 CHINA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 113 CHINA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 114 JAPAN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 115 JAPAN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 116 JAPAN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 117 JAPAN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 118 JAPAN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 119 INDIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 120 INDIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 121 INDIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 122 INDIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 123 INDIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 124 AUSTRALIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 125 AUSTRALIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 126 AUSTRALIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 127 AUSTRALIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 128 AUSTRALIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 129 SOUTH KOREA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 130 SOUTH KOREA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 131 SOUTH KOREA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 132 SOUTH KOREA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 133 SOUTH KOREA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 134 SINGAPORE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 135 SINGAPORE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 136 SINGAPORE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 137 SINGAPORE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 138 SINGAPORE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 139 MALAYSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 140 MALAYSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 141 MALAYSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 142 MALAYSIA LDL TEST MARKET, BY DISTRIBUTION CHAANEL, 2017-2026 (USD MILLION)
  • TABLE 143 MALAYSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 144 INDONESIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 145 INDONESIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 146 INDONESIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 147 INDONESIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 148 INDONESIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 149 THAILAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 150 THAILAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 151 THAILAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 152 THAILAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 153 THAILAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 154 PHILIPPINES LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 155 PHILIPPINES DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 156 PHILIPPINES LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 157 PHILIPPINES LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 158 PHILIPPINES LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 159 REST OF APAC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 160 SOUTH AMERICA LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 161 SOUTH AMERICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 162 SOUTH AMERICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 163 SOUTH AMERICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 164 SOUTH AMERICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 165 SOUTH AMERICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 166 BRAZIL LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 167 BRAZIL DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026 (USD MILLION)
  • TABLE 168 BRAZIL LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 169 BRAZIL LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 170 BRAZIL LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 171 REST OF SOUTH AMERICALDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 172 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 173 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 174 MIDDLE EAST AND AFRICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 175 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 176 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY DISTRIBUTION CHENNEL, 2017-2026 (USD MILLION)
  • TABLE 177 MIDDLE EAST AND AFRICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 178 SOUTH AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 179 SOUTH AFRICA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
  • TABLE 180 SOUTH AFRICA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION)
  • TABLE 181 SOUTH AFRICA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 182 SOUTH AFRICA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 183 REST OF MIDDLE EAST AND AFRICA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL LDL TEST MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL LDL TEST MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL LDL TEST MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL LDL TEST MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL LDL TEST MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL LDL TEST MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL LDL TEST MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL LDL TEST MARKET: THE MARKET CHALLENGE MATRIX
  • FIGURE 9 GLOBAL LDL TEST MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL LDL TEST MARKET
  • FIGURE 11 GLOBAL LDL TEST MARKET: SEGMENTATION
  • FIGURE 12 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL LDL TEST MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026
  • FIGURE 13 INCREASING GERIATRIC POPULATION, INCREASING OBESITY AND OVERWEIGHT POPULATION ARE EXPECTED TO DRIVE THE GLOBAL LDL TEST MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 14 KITS AND REAGENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LDL TEST MARKET IN 2019 & 2026
  • FIGURE 15 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH-AMERICA IS HAVING MOST PROFITABLE REVENUE POCKETS FOR GLOBAL LDL TEST MARKET IN THE FORECAST PERIOD FROM 2019 TO 2026
  • FIGURE 16 GLOBAL LDL TEST MARKET: BY COMPONENT, 2018
  • FIGURE 17 GLOBAL LDL TESTING MARKET: BY DISEASE, 2018
  • FIGURE 18 GLOBAL LDL MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 19 GLOBAL LDL TEST MARKET: BY END USER, 2018
  • FIGURE 20 GLOBAL LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 21 GLOBAL LDL TEST MARKET: BY GEOGRAPHY (2018)
  • FIGURE 22 GLOBAL LDL TEST MARKET: BY GEOGRAPHY (2019 & 2026)
  • FIGURE 23 GLOBAL LDL TEST MARKET T: BY COUNTRY (2018 & 2026)
  • FIGURE 24 GLOBAL LDL TEST MARKET: BY COMPONENTS (2019-2026)
  • FIGURE 25 NORTH AMERICA LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 26 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2018)
  • FIGURE 27 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 28 NORTH AMERICA LDL TEST MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 29 NORTH AMERICA LDL TEST MARKET: BY COMPONENTS (2019-2026)
  • FIGURE 30 EUROPE LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 31 EUROPE LDL TEST MARKET: BY COUNTRY (2018)
  • FIGURE 32 EUROPE LDL TEST MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 33 EUROPE LDL TEST MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 34 EUROPE LDL TEST MARKET: BY COMPONENTS (2019-2026)
  • FIGURE 35 ASIA-PACIFIC LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 36 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2018)
  • FIGURE 37 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 38 ASIA-PACIFIC LDL TEST MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 39 ASIA-PACIFIC LDL TEST MARKET: BY COMPONENTS (2019-2026)
  • FIGURE 40 SOUTH AMERICA LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 41 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2018)
  • FIGURE 42 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 43 SOUTH AMERICA LDL TEST MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 44 SOUTH AMERICA LDL TEST MARKET: BY COMPONENT (2019-2026)
  • FIGURE 45 MIDDLE EAST AND AFRICA LDL TEST MARKET: SNAPSHOT (2018)
  • FIGURE 46 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2018)
  • FIGURE 47 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2019 & 2016)
  • FIGURE 48 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 49 MIDDLE EAST AND AFRICA LDL TEST MARKET: BY COMPONENTS (2019-2026)
  • FIGURE 50 GLOBAL LDL TEST MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 51 NORTH AMERICA LDL TEST MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 52 EUROPE LDL TEST MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 53 ASIA PACIFIC LDL TEST MARKET: COMPANY SHARE 2018 (%)
Back to Top